This process effectively eliminates intracellular bacteria and reverses the promoting effects of Fn on EMT‐related protein expression and cytoskeletal remodeling in tumor cells, thereby enhancing the anti‐tumor efficacy of OXA (Figure 3J). The gene discussed is FN1; the disease is neoplasm.